Clinical Trial Update: Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating cannabidiol for reducing neuroinflammation in chronic back pain was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Back Pain
• Low Back Pain

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Back Pain, Low | Phase 4 | Status: TERMINATED | Results posted: 2022-04-13